Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Aflibercept for ROP Shows Sustained Efficacy at Age 3
A 0.4 mg dose of aflibercept in infancy to treat retinopathy of prematurity (ROP) shows sustained efficacy and safety at 3 years of age, according to research presented at EURETINA 2024. No significant ocular or systemic safety concerns were identified…
English